0001209191-17-065297.txt : 20171212
0001209191-17-065297.hdr.sgml : 20171212
20171212201439
ACCESSION NUMBER: 0001209191-17-065297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171208
FILED AS OF DATE: 20171212
DATE AS OF CHANGE: 20171212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kroll Werner
CENTRAL INDEX KEY: 0001609320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 171252862
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-08
0
0000353569
QUIDEL CORP /DE/
QDEL
0001609320
Kroll Werner
12544 HIGH BLUFF DRIVE, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
SVP, R&D
Common Stock
2017-12-08
4
M
0
7100
23.41
A
10818
D
Common Stock
2017-12-08
4
S
0
7100
40.4856
D
3718
D
Common Stock
2017-12-08
4
M
0
9258
23.41
A
12976
D
Common Stock
2017-12-08
4
S
0
9258
40.4063
D
3718
D
Non-Qualified Stock Option
23.41
2017-12-08
4
M
0
7100
0.00
D
2017-02-05
2025-02-05
Common Stock
7100
26854
D
Non-Qualified Stock Option
23.41
2017-12-08
4
M
0
9258
0.00
D
2017-02-05
2025-02-05
Common Stock
9258
17596
D
The weighted average sale price for these transactions was $40.485564 per share, with a range of $40.40 to $40.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $40.406319 per share, with a range of $40.36 to $40.45. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Robert J. Bujarski, attorney-in-fact for Werner Kroll
2017-12-12